Our recent publications further show that CSP or CSP7 reduces lung expression of TGF-β and CTGF to baseline levels after bleomycin-induced pulmonary fibrosis while preserving the viability of the AECs and preventing fLf expansion [14,16,21]. This evidence concerns the gene CCN2 and pulmonary fibrosis.